XSWX
CPHN
Market cap420mUSD
Jul 09, Last price
56.60CHF
1D
0.00%
1Q
-0.35%
Jan 2017
41.50%
IPO
-24.78%
Name
CPH Chemie und Papier Holding AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CPH Chemie + Papier Holding AG, alongside its various subsidiaries, is involved in the creation, production, and global sale of chemical products, printing paper, and specialized films designed for pharmaceutical packaging. Its Chemistry division, operating under the Zeochem brand, is dedicated to developing, manufacturing, and distributing a diverse array of molecular sieves, unique zeolites, chromatography gels, and deuterated solvents. The Paper division, known as Perlen Papier, is responsible for producing newsprint and magazine paper products, in addition to undertaking the recycling of domestically sourced paper. Furthermore, the Perlen Packaging division supplies the pharmaceutical industry with various PVC monofilms and coated PVdC high-barrier films. The company maintains a significant international presence, with operations in Switzerland, across Europe, throughout the Americas, in Asia, and other global regions. Established in 1818, the firm's main offices are located in Root, Switzerland.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||